Skip to content
Global Longlife Hospital and Research logo

Global Longlife Hospital and Research

543520 BSE
Price unavailable

Global Longlife Hospital and Research (GLHRL) share price was ₹12.08 at the 28 Oct 2026 close; market capitalisation ₹12.68 Cr; P/E (TTM) 6.71; sector Healthcare Services. The share price fell 49.1% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was under ₹1 Cr in both quarters and net profit was −₹0.40 Cr, against −₹1.04 Cr a year earlier (compared with Mar 2025). Promoters held 0.02% of Global Longlife Hospital and Research in Sep 2026, down 22.86 percentage points from Jun 2026. Its Tapetide Score is 42/100 (Weak) as of 28 Oct 2026.

Close 28 Oct 2026 ₹12.08 −11.64 −49.07% 1Y

Key Fundamentals

SMEHealthcare ServicesHealthcare
Market Cap
₹12.68 Cr
P/E (TTM)
6.71
EBITDA
−₹1.00 Cr
Return on Equity
-7.24%
Debt to Equity
0
Book Value
₹22.62
EPS (TTM)
₹1.80
52W High
₹25.80
52W Low
₹9.00

Price-based figures as of 28 Oct 2026, 15:30 IST · TTM

Peer Comparison

Healthcare › Healthcare Services › Hospitals › Hospital

Apollo Hospitals
₹8,232.5056.651,18,371 Cr12.490.26%20.08%19.79%26,675 Cr2,171 Cr
Manipal Health Enterprises
₹638.5585.1483,993 Cr5.110.00%10.42%9.50%11,400 Cr906 Cr
Max Healthcare Institute
₹860.4057.4483,744 Cr7.790.24%13.42%12.70%8,879 Cr1,457 Cr
Aster DM Healthcare
₹677.30110.1359,038 Cr14.030.45%8.84%9.71%5,006 Cr363 Cr
Fortis Healthcare
₹758.8054.6757,286 Cr5.790.14%10.47%12.13%9,607 Cr1,070 Cr
Global Health
₹1,301.6062.9134,996 Cr8.830.04%13.91%15.05%4,800 Cr552 Cr
Narayana Hrudayalaya
₹1,710.0042.8134,946 Cr7.700.26%17.85%11.39%9,185 Cr816 Cr
Global Longlife Hospital and Research (this company)
—6.7113 Cr0.530.00%-7.24%-4.16%24 Cr2 Cr
Median 8 companies₹860.4057.0558,162 Cr7.750.19%11.95%11.76%9,032 Cr861 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

42 Weak
Overall score

Data confidence 100/100

Category scores

Quality Poor 26
Returns, margins, earnings quality 22% weight
Valuation Strong 67
Cheap vs sector & own history 24% weight
Growth Poor 1
Sales & profit trajectory 9% weight
Financial Health Strong 73
Solvency, leverage, coverage 9% weight
Momentum Weak 39
Trend strength, vol-adjusted 12% weight
Ownership Poor 35
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Stock is trading at 0.59 times its book value

Weaknesses

4
  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -22.9%
  • Promoter holding is low: 0.02%
  • Company has a low return on equity of -8.85% over last 3 years.

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
6
Bullish
1

Overall

Bearish

Bearish
11
Neutral
6
Bullish
2

Moving Averages

Bearish

Bearish
9
Neutral
0
Bullish
1

Growth Rate

Revenue Growth
-100% level than 3Y

change over 1 year

Net Income Growth
-950% lower than 3Y

change over 1 year

Cash Flow Change
-137%

change over 1 year

EBITDA Margin Change
—

Quarterly Results

Particulars Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
19.94
12.87
11.8
11.7
12.33
1.18
0.58
0
0
0
Expenses
13.18
11.61
10.03
9.44
9.62
4.2
4.39
0.35
0.6
0.4
Operating Profit
6.76
1.26
1.77
2.26
2.71
-3.02
-3.81
-0.35
-0.6
-0.4
OPM %
33.9%
9.79%
15%
19.32%
21.98%
-255.93%
-656.9%
—
—
—
Other Income
0.07
0.16
0.07
0.17
0.02
0.04
5.69
-0.67
0.01
0
Interest
0.09
1.31
0.2
0.2
0.41
0.36
0.28
0
0
0
Depreciation
0.58
0.57
0.58
0.59
0.61
0.64
0.48
0
0
0
PBT
6.16
-0.46
1.06
1.64
1.71
-3.98
1.12
-1.02
-0.59
-0.4
Tax %
0%
-78.26%
29.25%
35.37%
39.77%
-19.1%
-11.61%
2.94%
123.73%
0%
Net Profit
6.17
-0.1
0.76
1.07
1.03
-3.22
1.24
-1.04
-1.32
-0.4
EPS (₹)
8.81
-0.14
0.72
1.02
0.98
-3.07
1.18
-0.99
-1.26
-0.38
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
33.44
33.32
32.7
32.44
23.38
13.46
0.31
0
Expenses
26.61
29.88
27.26
24.14
19.3
13.68
4.45
1
Operating Profit
6.83
3.44
5.44
8.3
4.08
-0.22
-4.14
-1
OPM %
20.42%
10.32%
16.64%
25.59%
17.45%
-1.63%
-1335.48%
—
Other Income
0.08
0.03
0.06
0.17
0.24
0
5.02
0.01
Interest
2.07
2.41
2.44
1.62
0.45
0.8
0.3
0
Depreciation
2.15
2.13
1.31
1.14
1.17
1.25
0.48
0
PBT
2.69
-1.07
1.75
5.71
2.7
-2.27
0.1
-0.99
Tax %
49.07%
-18.69%
-16.57%
37.3%
32.59%
-3.52%
-100%
73.74%
Net Profit
1.36
-0.86
2.05
3.57
1.83
-2.19
0.2
-1.72
EPS (₹)
1.94
-1.23
2.93
5.1
1.74
-2.09
0.19
-1.64
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
7
7
7
7
10.5
10.5
10.5
10.5
Reserves
5.35
4.49
6.68
9.96
53.79
15.43
16.29
13.25
Borrowings
27.18
23.51
17.04
8.69
9.29
12.74
0
0
Other Liabilities
3.77
6.92
6.06
8.33
2.36
3.07
0.06
0.01
Total Liabilities
43.3
41.92
36.78
33.98
75.94
41.74
26.85
23.76
Fixed Assets
20.17
18.72
17.46
16.71
16.52
17.27
0
0
CWIP
0
0
0
0
1.03
0
0
0
Investments
0.1
0.1
0.47
0.1
0.1
0.03
0.03
0
Other Assets
23.03
23.1
18.85
17.17
58.29
24.44
26.82
23.76
Total Assets
43.3
41.92
36.78
33.98
75.94
41.74
26.85
23.76
Figures in ₹ Crores

Cash Flow

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
5.4
3.9
6.88
9.42
-40.42
-5.07
12.32
-4.51
Investing
-0.33
-0.04
0.02
0.01
-1.9
-0.82
21.8
0.04
Financing
-4.77
-3.05
-7.22
-9.66
45.7
2.67
-13.01
0
Net Cash Flow
0.31
0.81
-0.33
-0.22
3.38
-3.22
21.11
-4.47
Free Cash Flow
5
3.79
6.84
8.96
-42.42
-6.1
33.42
-4.51
CFO/EBITDA
79
113
126
105
-960
2,259
-304
401
Figures in ₹ Crores

Ratios

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
94.85
68.68
87.51
100
151
52.88
377
—
Inventory Days
169
158
34.46
88.98
69.12
132
0
—
Days Payable
230
392
139
433
110
766
—
—
Cash Conversion Cycle
34.44
-165
-16.71
-244
110
-581
377
—
Working Capital Days
19.21
12.16
7.14
-29.7
345
-238
1,283
—
ROCE %
—
3.81%
12.75%
26.22%
6.35%
-2.51%
-13.69%
-3.92%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Global Longlife Hospital and Research insights

59 extracted metrics + investor summaries across FY15–FY26.

Shareholding Pattern

Public70.93%Promot.0.02%Others29.05%As ofSep 2026

Documents

Frequently Asked Questions about Global Longlife Hospital and Research

What does Global Longlife Hospital and Research Ltd do?
Incorporated in 2015, Global Longlife Hospital & Research Ltd is in the business of Health Care and Hospitals[1]
Where is Global Longlife Hospital and Research Ltd (GLHRL) listed?
Global Longlife Hospital and Research Ltd trades under code 543520 on the BSE.
Which sector does Global Longlife Hospital and Research Ltd belong to?
Global Longlife Hospital and Research Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the market capitalisation of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd has a market capitalisation of ₹12.68 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd trades at a PE ratio of 6.71 as of 28 Oct 2026, on earnings per share of ₹1.8, against a book value of ₹22.62 per share.
What is the 52-week high and low of Global Longlife Hospital and Research Ltd?
Over the last 52 weeks Global Longlife Hospital and Research Ltd has traded between ₹9 and ₹25.8 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Global Longlife Hospital and Research Ltd?
Global Longlife Hospital and Research Ltd reported a return on equity of -7.24%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 2015, Global Longlife Hospital & Research Ltd is in the business of Health Care and Hospitals[1]

Website globalhospital.co.in
Listed 2022-05-04
Face Value ₹ 10
Shares Outstanding 1,04,95,868

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543520.md for Global Longlife Hospital and Research Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month